Statin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Statin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • March 2020 •
  • 106 pages •
  • Report ID: 5878831 •
  • Format: PDF
The global statin market is currently witnessing stable growth.

Statin is a lipid-lowering medication, an agent that is consumed by patients to reduce their blood cholesterol levels. Atorvastatin, rosuvastatin, lovastatin and simvastatin are the most common types of statins available in the market. They aid in preventing the instances of atherosclerosis and heart attacks and have significant anti-inflammatory and plaque-stabilizing effects. These drugs also aid in minimizing vascular inflammation and oxidative stress in the body. Besides this, statin interferes with the production of enzymes that are crucial for the liver to produce cholesterol, thus aiding in lowering the overall blood cholesterol levels in the body.

The increasing prevalence of hypercholesterolemia across the globe is among the key factors driving the growth of the market. This disorder is highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, obesity and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, increasing consumer preference for over-the-counter (OTC) drugs is another factor contributing to the market growth. In comparison to brand name drugs, OTC variants are usually more affordable. Additionally, the growing adoption of combination therapies that use statin with other cholesterol diminishing compounds, such as ezetimibe, is acting as another growth-inducing factor. Research has found statin-ezetimibe combination therapy to be capable of achieving near-normal lipid profiles in familial hypercholesterolemia patients and significantly reducing the risk of CVDs occurrence. Other factors, including improving healthcare infrastructure and growing health consciousness among consumers, are projected to drive the market further.

This latest report provides a deep insight into the global statin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the statin industry in any manner.

Breakup by Type:
Synthetic Statins
Natural Statins

Breakup by Therapeutic Area:
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others

Breakup by Drug Class:
Atorvastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others

Breakup by Application:
Dyslipidemia
Others

Breakup by Distribution:
Hospitals
Clinics
Others

Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, AstraZeneca, Aurobindo Pharma, Biocon, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, etc.

Key Questions Answered in This Report:
How has the global statin market performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the therapeutic area?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the application?
What is the breakup of the market based on the distribution?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the market?
What is the structure of the global statin market and who are the key players?
What is the degree of competition in the market?